Omicron

Bitcoin below $50,000, at early October levels, after weekend’s battering

Bitcoin hovered around $49,000 on Monday, down 1.5% on the day, as traders nursed losses after a brutal weekend in…

4 years ago

U.S. & European stock futures rise, oil bounces

U.S. and European stocks futures moved higher on Monday as Asian markets lagged, while bonds surrendered some of their recent…

4 years ago

Google delays mandatory return to office beyond Jan. 10

Alphabet Inc's (GOOGL.O) Google said on Thursday it is indefinitely pushing back its January return-to-office plan globally amid growing concerns over the…

4 years ago

Omicron marches on as Biden prepares U.S. for grim winter

Australia, despite restrictions on international visitors, became the latest country on Friday to report community transmission of Omicron, a day…

4 years ago

U.S., Germany plan new restrictions as Omicron rattles investors

The United States and Germany joined countries around the globe planning stricter COVID-19 restrictions on Thursday as the new Omicron…

4 years ago

Asian shares tick up but Omicron worries leave markets on edge

Asian shares edged higher in choppy trading on Thursday, helped by advances in Chinese real estate shares, though fears about…

4 years ago

Asian factories shake off supply headaches but Omicron presents new risks

Asian factory activity grew in November as crippling supply bottlenecks eased, but rising input costs and renewed weakness in China…

4 years ago

Global airlines prepare for Omicron-induced volatility

Airlines are bracing for a fresh round of volatility due to the Omicron variant of COVID-19 that could force them…

4 years ago

Analysis: History says expect strong December for U.S. stocks, despite Omicron and Fed worries

A pileup of risks into year-end has some investors gauging whether December will continue its historical trend of a strong…

4 years ago

Futures slump on fresh Omicron worries after vaccine warning

U.S. stock index futures fell sharply on Tuesday after a warning from vaccine maker Moderna's chief executive on the effectiveness…

4 years ago